Trials / Conditions / MAP2K1 Gene Mutation
MAP2K1 Gene Mutation
3 registered clinical trials studyying MAP2K1 Gene Mutation — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations NCT05983159 | Murdoch Childrens Research Institute | Phase 2 |
| Terminated | Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations NCT04488003 | BioMed Valley Discoveries, Inc | Phase 2 |
| Active Not Recruiting | Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer NCT03087071 | M.D. Anderson Cancer Center | Phase 2 |